Neurometabolic Diseases Lab

Home

Facebook/ STOP ALD FOUNDATION

Monday, 20 May 2019 00:00 Juanjo Martínez

Important and exciting update for patients with AMN:

Biomarker Identification, Safety, and Efficacy of High-Dose Antioxidants for Adrenomyeloneuropathy: a Phase II Pilot Study

Ver el artículo en el link:

Last Updated on Sunday, 04 October 2020 11:09